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The term Asthma and COPD Overlap (ACO) describes a condition where asthma and
COPD overlap. We aimed to investigate associations between ACO and insomnia and
respiratory symptoms, and to investigate the prevalence of ACO and the characteristics of
subjects with ACO in two Northern European population studies.
Methods
The study comprised 25 429 subjects aged 40 years who participated in one of two North-
ern European general population surveys. Both surveys included questions on asthma,
COPD, respiratory and sleep-related symptoms, including difficulty initiating sleep, difficulty
maintaining sleep, early-morning awakening, and excessive daytime sleepiness. ACO was
defined as having both self-reported asthma and COPD.
Results
The prevalence of ACO was 1.0%. The group with ACO had a higher prevalence of both
insomnia and respiratory symptoms than subjects with only asthma or COPD. Having ACO
was independently associated with a 2–3 times higher probability of having sleep-related
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symptoms as compared with the group without asthma or COPD, after adjustment for age,
sex, BMI, smoking history and educational level (adjusted odds ratio 2.14–3.36, 95% CI).
Conclusion
Subjects with ACO have a high prevalence of insomnia and respiratory symptoms. To our
knowledge, this is the first study to assess the association between sleep-related symptoms
and ACO.
Introduction
Asthma and Chronic Obstructive Pulmonary Disease (COPD) can overlap and converge,
causing subjects to suffer from symptoms of both conditions. The term Asthma and COPD
Overlap (ACO) has been developed to describe this condition. GOLD and GINA guidelines
suggest a descriptive definition: Asthma-COPD overlap (ACO) is characterised by persistent
airflow limitation with several features usually associated with asthma and several features usu-
ally associated with COPD. ACO is thus, in clinical practice, identified by the features that it
shares with both asthma and COPD [1].
The prevalence of ACO has been studied in cohorts of patients with either COPD or
asthma, and found to be 13% to 55% [2,3]. The prevalence of ACO is estimated as being less
than 10% in COPD or asthma patients younger than 50 years and over 50% among patients
aged 80 years or older. The distinction between asthma and COPD becomes increasingly diffi-
cult with patient age; features of both conditions often coexist [2,3]. Subjects with ACO are
more likely to be women [2,3]. There is, however, limited data available on the prevalence of
ACO in general populations.
Subjects with ACO have frequent exacerbations, poor quality of life, and consume a dispro-
portionate amount of healthcare resources compared with patients with only asthma or COPD
[2,4,5]. Little is known about the underlying causes for their poor quality of life. However,
asthma and COPD have both been associated with sleep disturbances [6,7] and previous stud-
ies have shown that sleep disturbances have a large negative effect on quality of life [8]. Follow-
ing this line of argument, it is likely that the low quality of life in ACO found in previous
studies may partly be explained by sleep disturbances [3]. There is, however, no data on sleep
quality in patients with ACO.
We aimed to investigate associations between ACO and respiratory symptoms and insom-
nia symptoms, including difficulty initiating sleep, difficulty maintaining sleep, early-morning
awakening, and excessive daytime sleepiness, and to investigate the prevalence of ACO and




The participants were recruited from two ongoing population surveys in Northern Europe: the
GA2LEN survey and the RHINE III cohort.
The Global Allergy and Asthma Network in Europe (GA2LEN) is a research network in the
field of asthma and allergic diseases, consisting of research centres in 22 European countries
[9]. In 2008, the GA2LEN survey was sent to a random sample of 45 000 subjects aged 16–75
years in four Swedish cities (10 000 each in Uppsala, Stockholm and Umeå and 15 000 in
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Gothenburg) [6]. The questionnaire included questions on COPD, asthma, rhinitis, chronic
bronchitis, eczema and environmental and workplace exposure. In addition, the Swedish ques-
tionnaire also included questions on insomnia, physical activity and cardiovascular morbidity.
Up to three reminders were sent and 25 610 subjects (56.9%) responded. In the present analy-
ses, only subjects aged 40 years or older were included (N = 13 967).
Respiratory Health In Northern Europe (RHINE) is a large Northern European prospective
cohort study initiated in 1990–1992, with follow-ups in 1999–2000 (RHINE II) and in 2010–
2012 (RHINE III). The cohort was initially recruited as part of the European Community
Respiratory Health Survey (ECRHS) [10]. Random population samples of men and women
born 1945–73 completed postal, self-administered, questionnaires in the aforementioned time-
frames. The questionnaires included similar questions to those in the GA2LEN survey. The
Swedish questionnaires also included questions on sleep-related symptoms, comorbidities and
women’s health. In this study, we have used data from the RHINE III cohort, where sixty-two
percent (62%) of the original sample responded. In the present analyses, only subjects aged 40
years or older were included (N = 11 462).
In both studies, informed consent was obtained from each participant. The Regional Com-
mittees for Medical and Health Research Ethics West in Norway, the National Bioethics Com-
mittee in Iceland, the Research Ethics Committee of the University of Tartu in Estonia, The
Regional Ethical Review Board in Uppsala, Sweden and the Scientific Committees for Central
Jutland in Denmark approved the studies.
Definitions
The variables included in the present analyses were identical in both surveys.
Asthma was defined as a positive answer to either the question ‘Have you had an attack of
asthma in the last 12 months?’ or the question ‘Are you currently taking any medicine, includ-
ing inhalers, aerosols or tablets, for asthma?’ [11]. COPD was defined as a positive answer to
the question ‘Has a doctor ever told you that you have chronic obstructive pulmonary dis-
ease?’. ACO was defined as having both asthma and COPD according to the definitions given
above.
The questions on asthma-related symptoms included wheezing or whistling in the chest,
waking up with chest tightness, and waking up due to shortness of breath at any time in the
last 12 months. Response options were Yes or No.
Chronic bronchitis was defined as a positive answer to the question ‘Do you cough up
phlegm from your chest in the morning almost every day during at least 3 months each year?’.
The insomnia symptoms, difficulty initiating sleep (DIS), difficulty maintaining sleep
(DMS), early-morning awakening (EMA) and excessive daytime sleepiness (EDS), were
defined as reporting the symptom in question at least 3 nights or days per week [11].
Smoking was assessed through the question ‘Have you ever smoked one or more cigarettes
per day for more than one year?’. The question ‘Have you smoked at all during the last
month?’ was then used to separate ex-smokers from current smokers.
Educational level was categorized into the following three levels: nine-year elementary
school, high school and university.
Body mass index (BMI) was calculated from self-reported weight and height, as weight in
kilograms divided by height in meters squared.
Subsample with spirometry
Spirometry measurements were available from 2 099 subjects (1 376 from RHINE and 723
from the GA2LEN cohort). Lung function and reversibility were, in both surveys, assessed
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through spirometry (before and after bronchodilation with 200 μg salbutamol) using the Easy-
OneTM spirometer (ndd Medizintechnik AG, Zürich, Switzerland). The ratio of the post-
bronchodilatory forced expiratory volume in one second (FEV1) and the forced vital capacity
(FVC) was calculated and a ratio below 0.70 was used to indicate persistent airflow obstruction
(AO) [1]. Based on these results, four groups were identified: (a) controls without AO (n = 1
491), (b) diagnosed COPD with AO (n = 6), (c) diagnosed asthma without AO (n = 247) and
(d) ACO with AO (n = 29). As group b was so small, it was excluded from the analyses.
Statistical analyses
All statistical analyses were conducted using Stata 14 (StataCorp, Texas, USA). Univariate
analyses were performed with the chi-square test and the unpaired t-test. Multiple logistic
regression was used to calculate adjusted odds ratios (OR) and 95% confidence intervals (95%
CI) for risk analyses. Interaction analyses were performed to assess a possible modifying effect
of sex on ACO. A p value of< 0.05 was considered significant.
Results
In the whole cohort, 362 subjects (1.4%) reported having COPD but not asthma, 1 665 (6.6%)
reported asthma without COPD and 250 subjects (1.0%) reported ACO (Fig 1). The prevalence
of ACO among the participants with reported asthma was 13.1%, while the prevalence among
those with reported COPD was 40.8%. The prevalence of ACO was higher in women than
men in all age groups (p< 0.001) (Fig 2). The prevalence of ACO was highest in the age group
55–64 years.
The demographic characteristics of the subjects are presented in Table 1. The subjects in
the groups with asthma and ACO were more often women, while the groups with COPD and
ACO had the highest mean age. The group with ACO had the highest mean BMI. The group
with COPD alone and the ACO group had the highest prevalence of smoking and the lowest
educational level.
Fig 1. Overlap of asthma and COPD.
https://doi.org/10.1371/journal.pone.0195055.g001
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The prevalence of insomnia symptoms and the prevalence of respiratory symptoms are pre-
sented in Table 2. The group with ACO had the highest prevalence of both insomnia and respi-
ratory symptoms. Women had higher a prevalence of insomnia symptoms (Fig 3), but the
relative difference in prevalence between the ACO group and controls was similar in men and
women.
Multivariate analyses
The strongest association with sleep-related and respiratory symptoms was seen in the group
with ACO also after adjustment for age, sex, BMI, smoking history, study centre and educa-
tional level (Table 3). Interaction analyses showed no modifying effect of sex on the association
between ACO and respiratory or sleep-related symptoms (pinteraction = 0.16–0.99). Having only
asthma or COPD was also associated with a higher risk for all sleep-related and respiratory
symptoms (Table 3).
Fig 2. Prevalence of asthma, COPD and ACO in relation to age and sex.
https://doi.org/10.1371/journal.pone.0195055.g002
Table 1. Characteristics of the population (% and mean ± SD).
No asthma and/or COPD
n = 23 152
Asthma






Female sex 51.7 60.2 55.8 60.0 < 0.0001
Age (years) 54.1±8.8 53.3±8.6 58.8±8.6 57.0±7.8 < 0.0001
Body mass index (kg/m2) 25.7±4.1 26.8±4.9 26.7±5.0 27.7±5.6 < 0.0001
Smoking history < 0.0001
Never 48.6 49.4 17.0 18.2
Ex-smoker 35.4 37.6 47.9 44.8
Current 15.9 13.0 35.1 37.1
Highest education level < 0.0001
Elementary school 17.4 17.0 36.5 40.7
High school 35.7 37.3 33.4 37.5
University 46.9 45.7 30.1 21.8
https://doi.org/10.1371/journal.pone.0195055.t001
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In addition, study-specific analyses showed that the associations between ACO and sleep-
related or respiratory symptoms were highly significant in both populations, although the
association was stronger in the GA2LEN population than in the RHINE III population for
most symptoms (Table 4).
Analyses of subsample with spirometry results. In the subsample with spirometry
results, the strongest association with DIS, EMA and all respiratory symptoms was seen in the
group with ACO and spirometry-defined airway obstruction (AO) after adjustment for age,
sex, BMI, smoking history and educational level (Table 5).
Discussion
The main finding in this community-based study is that subjects with asthma and COPD over-
lap have a high burden of insomnia and respiratory symptoms. These associations remained
significant after adjustment for age, sex, BMI, smoking history and educational level.
The prevalence of insomnia symptoms was highest in the group with ACO overlap. This is
a novel finding and has, to our knowledge, not been previously analysed, even though other
studies have reported a higher burden of sleep problems in both patients with only asthma
[6,12] and those with only COPD [7]. As sleep disturbances have a large negative effect on
quality of life [8] it is likely that the low quality of life in ACO found in previous studies [3] is
Table 2. Sleep-related and respiratory symptoms (%).
No asthma and/or COPD
n = 23 152
Asthma






Difficulty initiating sleep 11.3 18.8 27.7 37.3 < 0.0001
Difficulty maintaining sleep 32.3 40.7 43.4 53.9 < 0.0001
Early-morning awakening 16.7 22.8 26.9 39.7 < 0.0001
Excessive daytime sleepiness 21.9 33.4 39.0 45.2 < 0.0001
Wheeze 12.7 71.4 48.9 83.7 < 0.0001
Nocturnal chest tightness 7.8 37.7 25.0 52.4 < 0.0001
Nocturnal breathlessness 3.8 20.1 14.4 35.7 < 0.0001
Nocturnal cough 22.0 51.6 45.0 63.6 < 0.0001
Chronic bronchitis 7.8 28.6 32.7 43.3 < 0.0001
https://doi.org/10.1371/journal.pone.0195055.t002
Fig 3. Prevalence of sleep-related symptoms in relation to asthma and COPD in men and women. (Controls:
subjects with no self-reported respiratory condition, difficulty initiating sleep (DIS), difficulty maintaining sleep
(DMS), early morning awakenings (EMA), excessive daytime sleepiness (EDS).
https://doi.org/10.1371/journal.pone.0195055.g003
Asthma and COPD overlap in relation to sleep disturbances
PLOS ONE | https://doi.org/10.1371/journal.pone.0195055 April 2, 2018 6 / 10
partly explained by this disturbed sleep quality. A high prevalence of fatigue in COPD has
been reported in previous studies [13]. In a previous study, we found that COPD was more
closely associated with sleep disturbances in men than in women [7]. In the present study,
however, the association between sleep disturbances and ACO was similar in men and
women, although the prevalence of sleep disturbances was higher in women in all groups.
The ACO group had a higher prevalence of wheeze than the groups with only asthma or
only COPD. This is in accordance with results from the EPI-SCAN [3] and ECRHS I-II sur-
veys [2]. The same was true for the prevalence of chronic bronchitis. This result is in accor-
dance with data from the CHAIN cohort [14] and from ECRHS I-II [2] but not with data from
EPI-SCAN [3].
The prevalence of ACO observed in our study was 1.0%. This is in agreement with previous
findings from studies on general adult population samples [4]. In the present study, 13% of the
asthmatics also had self-reported COPD. This is fairly similar to what has been found in other
studies with participants with obstructive airway disease [15,16]. The high prevalence of ACO
in those with reported COPD in the present study (41%) is probably related to that mean age
was almost 60 years which is within the age interval with the highest prevalence of ACO. It is
also possible that the high prevalence of ACO in the COPD group is an overestimation due to
incorrect diagnosis.
Table 3. Sleep-related and respiratory symptoms (adjusted odds ratio (95% CI)).
No asthma and/or COPD
n = 23 152
Asthma





Difficulty initiating sleep 1 1.77 (1.54–2.02) 2.15 (1.68–2.77) 3.36 (2.55–4.43)
Difficulty maintaining sleep 1 1.37 (1.24–1.53) 1.32 (1.06–1.65) 2.14 (1.65–2.78)
Early-morning awakening 1 1.45 (1.28–1.64) 1.59 (1.24–2.04) 3.00 (2.30–3.91)
Excessive daytime sleepiness 1 1.66 (1.49–1.86) 2.18 (1.74–2.73) 2.69 (1.07–3.50)
Wheeze 1 21.0 (18.6–23.7) 5.53 (4.39–6.96) 31.2 (21.8–44.7)
Nocturnal chest tightness 1 7.10 (6.33–7.96) 3.60 (2.80–4.63) 11.5 (8.82–15.0)
Nocturnal breathlessness 1 6.31 (5.47–7.29) 4.11 (2.99–5.66) 15.1 (11.3–20.1)
Nocturnal cough 1 3.58 (3.22–3.97) 2.72 (2.19–3.39) 5.70 (4.34–7.47)
Chronic bronchitis 1 5.75 (5.06–6.53) 4.41 (3.44–5.64) 9.07 (6.83–12.0)
adjusted for age, sex, BMI, smoking history, educational level and centre.
https://doi.org/10.1371/journal.pone.0195055.t003
Table 4. Association between ACO and sleep-related and respiratory symptoms in the GA2LEN and RHINE III
populations, with participants without asthma and COPD as the reference group (adjusted odds ratio (95% CI)).
GA2LEN
n = 13 967
RHINE III
n = 11 462
Difficulty initiating sleep 3.74 (2.38–5.89) 3.12 (2.19–4.43)
Difficulty maintaining sleep 2.44 (1.57–3.79) 1.92 (1.39–2.68)
Early-morning awakening 3.97 (2.58–6.11) 2.46 (1.74–3.48)
Excessive daytime sleepiness 4.75 (3.06–7.38) 1.89 (1.35–2.66)
Wheeze 73.8 (33.5–162) 21.5 (14.2–32.6)
Nocturnal chest tightness 19.5 (12.3–30.9) 8.38 (6.00–11.7)
Nocturnal breathlessness 18.6 (11.9–29.0) 12.6 (8.51–18.6)
Nocturnal cough 6.19 (3.90–9.81) 5.32 (3.80–7.44)
Chronic bronchitis 10.9 (6.89–17.24) 7.97 (5.47–11.6)
adjusted for age, sex, BMI, smoking history, educational level and centre.
https://doi.org/10.1371/journal.pone.0195055.t004
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As in previous studies, ACO was more common in women [3]. The groups with ACO and
COPD had a higher BMI than the asthmatics and healthy controls. This was also true for the
ACO groups in the CHAIN [14] and EPI-SCAN cohorts [3]. The groups with COPD and
ACO had the highest prevalence of smoking. This is also in agreement with data from the
EPI-SCAN [3] and CHAIN cohorts [14]. The lowest prevalence of university education was
seen in the COPD and ACO groups. Data from the ECRHS I-II cohorts showed the lowest
educational level for the ACO group [2]. Patients with ACO could either be patients with
severe asthma that have developed fixed airflow obstruction as a result of remodelling [2] or
COPD patients with asthmatic features. The fact that the characteristics of the ACO group and
the COPD group were relatively similar indicate that the second of these two phenotypes dom-
inate in the present study.
Our analysis has an inherent strength: it is the first study to describe the asthma-COPD
overlap in two distinct community-based populations and to examine sleep-related symptoms
in the overlap groups. Other inherent strengths are the large population samples, the consis-
tency of our results in both population samples and the use of validated questionnaire tools.
Our study also has several limitations. Concerns could be raised about the reliability of self-
reported diagnoses, both for asthma and COPD. Dissecting the phenotypes in asthma, COPD
and ACO is challenging. Recall bias or physician misdiagnosis cannot be excluded. In addition,
ACO is generally used as a potential diagnosis only in adults over 40 years [17] and we there-
fore used a lower age limit of 40 years for diagnosis in an attempt to better capture early-onset
COPD. Moreover, in the GA2LEN and RHINE III cohorts, we only had data regarding pulmo-
nary function in a subsample of the population. The results were, however, relatively similar
when we only included participants with spirometry results. Additionally, although the
response rates for the GA2LEN and RHINE III surveys were 57% and 62%, respectively, previ-
ous studies on the RHINE III cohort have shown that lower response rates slightly affected
prevalence estimates but did not at all affect associations between predictors and outcomes
[11]. Finally, the cross-sectional nature of our study is an additional disadvantage.
In conclusion, subjects with “Asthma and COPD Overlap (ACO)” suffer from a higher bur-
den of insomnia symptoms, i.e., difficulty initiating sleep, difficulty maintaining sleep, early-
morning awakening, and excessive daytime sleepiness, and respiratory symptoms, including
wheeze, nocturnal chest tightness, nocturnal breathlessness and nocturnal cough. Subjects
with ACO may thus need specific interventions to be adequately cared for. Women are more
likely to be present in the overlap and asthma populations. Future therapeutic studies are
Table 5. Sleep-related and respiratory symptoms (adjusted odds ratio (95% CI)) in participants with available
spirometric data.
No asthma and/or COPD





Difficulty initiating sleep 1 1.50 (0.999–2.24) 2.59 (1.07–6.24)
Difficulty maintaining sleep 1 1.18 (0.88–1.57) 0.86 (0.39–1.87)
Early-morning awakening 1 1.51 (1.07–2.11) 2.74 (1.24–6.03)
Excessive daytime sleepiness 1 1.99 (1.48–2.68) 2.08 (0.93–4.67)
Wheeze 1 16.2 (11.6–22.8) 29.8 (9.92–89.5)
Nocturnal chest tightness 1 6.40 (4.61–8.88) 18.3 (7.95–41.9)
Nocturnal breathlessness 1 5.15 (3.36–7.91) 15.0 (6.47–34.6)
Nocturnal cough 1 3.25 (2.44–4.32) 6.53 (2.88–14.8)
Chronic bronchitis 1 6.75 (4.77–9.55) 11.7 (5.15–26.5)
adjusted for age, sex, BMI, smoking history and educational level.
https://doi.org/10.1371/journal.pone.0195055.t005
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needed to identify optimal treatment approaches for patients with concurrent asthma and
COPD.
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Gı́slason, Rain Jõgi, Karl A. Franklin, Mathias Holm, Ane Johannessen, Roelinde Middel-
veld, Vivi Schlünssen, Cecilie Svanes, Kjell Torén, Eva Lindberg.
References
1. Global Initiative for Asthma Scientific C: 2016 GINA Report, Global Strategy for Asthma Management
and Prevention Avaialble from. http://ginasthma.org/wp-content/uploads/2016/04/wms-GINA-2016-
main-report-final.pdf. Accessed: 10 September 2017
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